{"database": "lobbying", "table": "lobbying_activities", "rows": [[2181463, "05c4990a-118a-4aea-857b-525cf647aee2", "Q3", "RED+BLUE STRATEGIES", 400693064, "CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP)", 2018, "third_quarter", "MMM", "Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.\n\nS. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.\n\nTrump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers. \n\nIssues related to making health care in the United States of America more transparent and consumer-focused.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2018-10-09T15:36:28.393000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2181463"], "units": {}, "query_ms": 125.47078396892175, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}